University of Queensland researchers have found targeting amyloid plaque in the brain is not essential for ultrasound to deliver cognitive improvement in neurodegenerative disorders.
Corrected: Sangamo to seek accelerated approval for Fabry gene therapy, claims it won’t need confirmatory study
Sangamo Therapeutics thinks it’s found a faster, earlier pathway to approval for its Fabry disease gene therapy. The biotech announced Tuesday that it plans to
October 23, 2024